Clinical Trials and Research

AbstractIntroductionTransthyretin amyloidosis (ATTR) is a multisystemic disease impacting quality of life (QOL) through various symptoms. The Transthyretin…

AbstractBACKGROUND:Diagnosing cardiac amyloidosis (CA) on echocardiography can be challenging due to the imaging overlap between CA and more prevalent causes of a…

Study OverviewBrief SummaryThe TRACE-AI Diagnostic Study will evaluate the performance of artificial intelligence (AI) models applied to electrocardiograms (AI-ECG…

Despite the proven efficacy of tafamidis in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), real-world treatment decisions often involve…

This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be…

Cardiac amyloidosis is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins, most commonly immunoglobulin light chains (AL) or…

Overview This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance…

Recommendations outline best practices for diagnosing rare, complex bone marrow disorder(WASHINGTON — Jan. 28, 2026) — The American Society of Hematology (ASH)…

Cardiac amyloidosis (CA) represents an increasingly recognized but historically underdiagnosed cause of restrictive cardiomyopathy and heart failure. CA is now…

Study OverviewBrief SummaryThis study intends to conduct a prospective observation to investigate the prevalence of cardiac amyloidosis (CA) in patients with aortic…